Work

The Hippo Effector Transcriptional Coactivator with PDZ-Binding Motif Cooperates with Oncogenic β-Catenin to Induce Hepatoblastoma Development in Mice and Humans

Year: 2020

Type: article

Source: American Journal Of Pathology

DOI: 10.1016/j.ajpath.2020.03.011

Authors: Shu Zhang, Jie Zhang, Katja Evert, Xiaolei Li, Pin Liu, Andras Kiss, Zsuzsa Schaff, Cindy Ament, Yi Zhang, Monica Serra, Matthias Evert, Nianyong Chen, Feng Xu, Xin Chen, Junyan Tao, Diego F. Calvisi, Antonio Cigliano

Institutions: University of California, San Francisco, Sichuan University, West China Medical Center of Sichuan University, West China Hospital of Sichuan University, State Key Laboratory of Biotherapy, Peking University Cancer Hospital, University of Regensburg, Chinese People's Liberation Army, Zhongnan Hospital of Wuhan University, Semmelweis University, Chongqing University, University of Sassari, University of Pittsburgh

Language: English

Topic: Hippo pathway signaling and YAP/TAZ

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Natural Science Foundation of China, Associazione Italiana per la Ricerca sul Cancro, Universität Regensburg, National Institutes of Health, University of California, San Francisco, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, Liver Center, University of California, San Francisco

Awards: G1978185739, G208418196, G2231105319, Yap and beta-catenin interactions in liver: Implications in Pathophysiology, G4428381168, G5002509932, G559381009, G7469692052, G7798197570, G8071400486, UCSF Liver Center

OpenAlex ID: W3015932864

FWCI: 3.615

Cites: 41

Cited by: 35

Related to: 10